Justin Gover is a senior biotech executive and the former CEO of GW Pharmaceuticals, a company he led for over 20 years. Holding an MBA from INSEAD, he now serves on the boards of several clinical-stage companies, focusing on developing novel therapies for neurological and rare diseases.
His professional work is deeply connected to patient advocacy. He is the Chairperson of the Board for CURE Epilepsy, a non-profit dedicated to funding research, and actively expresses his commitment to supporting patient communities like those affected by Tuberous Sclerosis Complex (TSC).
He successfully led GW Pharmaceuticals from a startup to its $7. 2 billion acquisition, overseeing the launch of the first FDA-approved plant-derived cannabinoid medicine.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.